![Karim AMIGHI | PhD Pharmaceutical sciences | Université Libre de Bruxelles, Brussels | ULB | Laboratory of Pharmaceutics and Biopharmaceutics (ULBGAL) | Research profile Karim AMIGHI | PhD Pharmaceutical sciences | Université Libre de Bruxelles, Brussels | ULB | Laboratory of Pharmaceutics and Biopharmaceutics (ULBGAL) | Research profile](https://www.researchgate.net/publication/354896274/figure/fig1/AS:1073110451240960@1632860877109/Bar-plots-showing-F-values-and-associated-p-values-determining-the-statistical_Q320.jpg)
Karim AMIGHI | PhD Pharmaceutical sciences | Université Libre de Bruxelles, Brussels | ULB | Laboratory of Pharmaceutics and Biopharmaceutics (ULBGAL) | Research profile
![PDF) Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties | Karim Amighi - Academia.edu PDF) Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties | Karim Amighi - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/44730172/mini_magick20190213-25659-1j1i2fy.png?1550122683)
PDF) Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties | Karim Amighi - Academia.edu
Karim Amighi on Twitter: "Artificial Revolutions of IRAN(Persia): Model for misusing of other oil ... https://t.co/zIg04SHI7Q via @YouTube" / Twitter
ULB - Université libre de Bruxelles - Paroles de chercheurs Un nouveau médicament délivré par voie pulmonaire avec Karim Amighi, Laboratoire de pharmacie galénique et de biopharmacie Le Laboratoire de pharmacie galénique
![Rémi ROSIÈRE | Inhalation (DPI) Formulation Scientist | PhD, PharmD | Université Libre de Bruxelles, Brussels | ULB | Laboratory of Pharmaceutics and Biopharmaceutics (ULBGAL) | Research profile Rémi ROSIÈRE | Inhalation (DPI) Formulation Scientist | PhD, PharmD | Université Libre de Bruxelles, Brussels | ULB | Laboratory of Pharmaceutics and Biopharmaceutics (ULBGAL) | Research profile](https://i1.rgstatic.net/ii/profile.image/655523129081861-1533300301123_Q512/Remi-Rosiere.jpg)
Rémi ROSIÈRE | Inhalation (DPI) Formulation Scientist | PhD, PharmD | Université Libre de Bruxelles, Brussels | ULB | Laboratory of Pharmaceutics and Biopharmaceutics (ULBGAL) | Research profile
![PDF) Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties | Karim Amighi and Thami Sebti - Academia.edu PDF) Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties | Karim Amighi and Thami Sebti - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/44730164/mini_magick20190213-16108-121fhcb.png?1550122697)
PDF) Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties | Karim Amighi and Thami Sebti - Academia.edu
![Karim Amighi, PhD - Editorial Board - Journal of Drug Delivery Science and Technology - Journal - Elsevier Karim Amighi, PhD - Editorial Board - Journal of Drug Delivery Science and Technology - Journal - Elsevier](https://ars.els-cdn.com/content/image/X17732247.jpg)
Karim Amighi, PhD - Editorial Board - Journal of Drug Delivery Science and Technology - Journal - Elsevier
![PDF] Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine by Jérôme Hecq, Michel Deleers, D. Fanara, Henri Vranckx, Karim Amighi · 10.1016/j.ijpharm.2005.05.014 · OA.mg PDF] Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine by Jérôme Hecq, Michel Deleers, D. Fanara, Henri Vranckx, Karim Amighi · 10.1016/j.ijpharm.2005.05.014 · OA.mg](https://og.oa.mg/Preparation%20and%20characterization%20of%20nanocrystals%20for%20solubility%20and%20dissolution%20rate%20enhancement%20of%20nifedipine.png?author=%20J%C3%A9r%C3%B4me%20Hecq,%20Michel%20Deleers,%20D.%20Fanara,%20Henri%20Vranckx,%20Karim%20Amighi)
PDF] Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine by Jérôme Hecq, Michel Deleers, D. Fanara, Henri Vranckx, Karim Amighi · 10.1016/j.ijpharm.2005.05.014 · OA.mg
![Frederic OPRENYESZK | Scientific Researcher - R&D Co-manager | Doctor of biomedecine and pharmaceutical science | Research profile Frederic OPRENYESZK | Scientific Researcher - R&D Co-manager | Doctor of biomedecine and pharmaceutical science | Research profile](https://i1.rgstatic.net/ii/profile.image/11431281129233537-1679498781105_Q512/Frederic-Oprenyeszk.jpg)
Frederic OPRENYESZK | Scientific Researcher - R&D Co-manager | Doctor of biomedecine and pharmaceutical science | Research profile
![Faculté de pharmacie : première rencontre des membres du G3 - Faculté de pharmacie - Université de Montréal Faculté de pharmacie : première rencontre des membres du G3 - Faculté de pharmacie - Université de Montréal](https://pharm.umontreal.ca/fileadmin/pharmacie/uploads/pics/g3-pharmacie-breton-2e03e11365627604.jpg)
Faculté de pharmacie : première rencontre des membres du G3 - Faculté de pharmacie - Université de Montréal
![Karim AMIGHI | PhD Pharmaceutical sciences | Université Libre de Bruxelles, Brussels | ULB | Laboratory of Pharmaceutics and Biopharmaceutics (ULBGAL) | Research profile Karim AMIGHI | PhD Pharmaceutical sciences | Université Libre de Bruxelles, Brussels | ULB | Laboratory of Pharmaceutics and Biopharmaceutics (ULBGAL) | Research profile](https://www.researchgate.net/profile/Nathalie-Wauthoz/publication/366052775/figure/fig1/AS:11431281106092471@1670590100938/CIS-DPI-induces-regulation-of-PD-L1-in-lung-tumours-A-Immunohistochemistry-with_Q320.jpg)